Evidence map›Paper›PMID 36037216›Full record

ArticlePloS one2022

Competing health risks associated with the COVID-19 pandemic and early response: A scoping review.

Stefan Baral, Amrita Rao, Jean Olivier Twahirwa Rwema, Carrie Lyons, Muge Cevik, Anna E Kågesten, Daouda Diouf, Annette H Sohn, Refilwe Nancy Phaswana-Mafuya, Adeeba Kamarulzaman and 3 more

Open access · goldAbstract readScoping Review
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 7 countries.

Stefan BaralDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland, United States of America.
Amrita RaoDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland, United States of America.ORCID 0000-0002-9596-2418
Jean Olivier Twahirwa RwemaDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland, United States of America.ORCID 0000-0002-7954-1736
Carrie LyonsDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland, United States of America.
Muge CevikDivision of Infection and Global Health Research, School of Medicine, University of St. Andrews, St. Andrews, Scotland.
Anna E KågestenDepartment of Global Public Health, Karolinska Institutet, Solna, Sweden.
Daouda DioufEnda Santé, Dakar, Senegal.
Annette H SohnTREAT Asia, amfAR, The Foundation for AIDS Research, Bangkok, Thailand.
Refilwe Nancy Phaswana-MafuyaSouth African Medical Research Council/University of Johannesburg Pan African Centre for Epidemics Research Extramural Unit, Johannesburg, South Africa.
Adeeba KamarulzamanDepartment of Medicine and Infectious Diseases, University of Malaya, Kuala Lumpur, Malaysia.
Gregorio MillettPublic Policy Office, amfAR, Washington, District of Columbia, United States of America.
Julia L MarcusDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, United States of America.
Sharmistha MishraLi Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Canada.
Johns Hopkins University · USEnvironment and Development Action Third World · SNHarvard University · USKarolinska Institutet · SEPublic Policy Institute of California · USSouth African Medical Research Council · ZASt. Michael's Hospital · CAUniversity of Malaya · MYUniversity of St Andrews · GB

Funding

Johns Hopkins HIV Epidemiology and Prevention Sciences Training ProgramT32AI102623 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta · 2013 to 2026
$5.3M
Optimizing Care for HIV/HCV-Coinfected Patients in the New HCV Treatment EraK01AI122853 · NIAID · KAISER FOUNDATION RESEARCH INSTITUTE · PI MARCUS, JULIA L. · 2016 to 2020
$655k
PrEP among high-risk young women in South Africa: real-world barriers to use and patterns of re-initiation and PrEP cyclingF31MH124458 · NIMH · JOHNS HOPKINS UNIVERSITY · PI RAO, AMRITA · 2020 to 2021
$86k
Understanding multilevel barriers and facilitators to HIV treatment among marginalized women living with HIV in the context of intersecting HIV, TB, and COVID-19 pandemicsF31MH128079 · NIMH · JOHNS HOPKINS UNIVERSITY · PI LYONS, CARRIE ELIZABETH · 2022 to 2023
$61k
NIAID NIH HHS K01 AI122853NIAID NIH HHS T32 AI102623NIMH NIH HHS F31 MH124458NIMH NIH HHS F31 MH128079
6 · The paper itself

Abstract

backgroundCOVID-19 has rapidly emerged as a global public health threat with infections recorded in nearly every country. Responses to COVID-19 have varied in intensity and breadth, but generally have included domestic and international travel limitations, closure of non-essential businesses, and repurposing of health services. While these interventions have focused on testing, treatment, and mitigation of COVID-19, there have been reports of interruptions to diagnostic, prevention, and treatment services for other public health threats.

objectivesWe conducted a scoping review to characterize the early impact of COVID-19 on HIV, tuberculosis, malaria, sexual and reproductive health, and malnutrition.

methodsA scoping literature review was completed using searches of PubMed and preprint servers (medRxiv/bioRxiv) from November 1st, 2019 to October 31st, 2020, using Medical Subject Headings (MeSH) terms related to SARS-CoV-2 or COVID-19 and HIV, tuberculosis, malaria, sexual and reproductive health, and malnutrition. Empiric studies reporting original data collection or mathematical models were included, and available data synthesized by region. Studies were excluded if they were not written in English.

resultsA total of 1604 published papers and 205 preprints were retrieved in the search. Overall, 8.0% (129/1604) of published studies and 10.2% (21/205) of preprints met the inclusion criteria and were included in this review: 7.3% (68/931) on HIV, 7.1% (24/339) on tuberculosis, 11.6% (26/224) on malaria, 7.8% (19/183) on sexual and reproductive health, and 9.8% (13/132) on malnutrition. Thematic results were similar across competing health risks, with substantial indirect effects of the COVID-19 pandemic and response on diagnostic, prevention, and treatment services for HIV, tuberculosis, malaria, sexual and reproductive health, and malnutrition. DISCUSSION: COVID-19 emerged in the context of existing public health threats that result in millions of deaths every year. Thus, effectively responding to COVID-19 while minimizing the negative impacts of COVID-19 necessitates innovation and integration of existing programs that are often siloed across health systems. Inequities have been a consistent driver of existing health threats; COVID-19 has worsened disparities, reinforcing the need for programs that address structural risks. The data reviewed here suggest that effective strengthening of health systems should include investment and planning focused on ensuring the continuity of care for both rapidly emergent and existing public health threats.

Indexed as

COVID-19HIV InfectionsMalariaMalnutritionTuberculosisHumansPandemicsSARS-CoV-2

Identifiers

PMID36037216
PMCPMC9423636
OpenAlexW4293469409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.